Establishment And Characterization Of A Novel Philadelphia- Chromosoe Positive Chronic Myeloid Leukemia Cell Line, TCC-S, Expressing P210 And P190 BCR/ABL Transcripts But Missing Normal ABL Gene

This publication has 24 references indexed in Scilit:

• Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia
  Blood, 2005
• A comparison of different metaphase CGH methods for the detection of cryptic chromosome aberrations of defined size
  European Journal of Human Genetics, 2004
• Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment
  New England Journal of Medicine, 2003
• Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis
  Blood, 2001
• The molecular biology of chronic myeloid leukemia.
  2000
• No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.
  1999
• Editorial
  Leukemia Research, 1999
• Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha.
  1998
• The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype.
  1996
• p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias
  Blood, 1996